Alterola Biotech, Inc. (ABTI)

Market Cap	296.25M
Revenue (ttm)	n/a
Net Income (ttm)	-2.78M
Shares Out	1.48B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20
Average Volume	2
Open	0.2000
Previous Close	0.0002
Day's Range	0.0002 - 0.2000
52-Week Range	0.0002 - 0.2000
Beta	77.44
RSI	99.64
Earnings Date	Jul 17, 2025

About Alterola Biotech

Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech, Inc. is based in Birkenhead, the United Kingdom.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: David Hitchcock
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: ABTI